AutoGenomics Withdraws IPO | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – AutoGenomics has pulled its initial public offering.

On Wednesday, the Vista, Calif.-based company filed papers with the US Securities and Exchange Commission for the "immediate withdrawal" of its registration statement for its IPO.

No reason was given for the decision.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.